Aristeia Capital’s Pear Therapeutics, Inc. Warrant PEARW Stock Holding History

Aristeia Capital’s Portfolio PEARW Stock Details PEARW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-400,000	Closed	-$246K	–	864
2021 Q4	$246K	Hold	400,000	–	–	﹤0.01%	513
2021 Q3	$366K	Hold	400,000	–	–	0.01%	430
2021 Q2	$592K	Buy	+400,000	New	+$349K	0.01%	380

Other funds holding PEARW

LMR Partners London, United Kingdom $10.9B AUM 60.68% 1-Year Est. Return

Highbridge Capital Management New York $1.58B AUM 31.19% 1-Year Est. Return

P. Schoenfeld Asset Management (PSAM) New York $126M AUM 97.09% 1-Year Est. Return

Owl Creek Asset Management New York $518M AUM 59.67% 1-Year Est. Return

Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return

Angelo Gordon & Co New York $1.06B AUM 47.95% 1-Year Est. Return

Kingstown Capital Management New York $30.4M AUM 3.71% 1-Year Est. Return

Sculptor Capital New York $8.88B AUM 27.49% 1-Year Est. Return